Unique Drug Slows Progression of Diabetic Kidney Disease

Unique Drug Slows Progression of Diabetic Kidney Disease

Uncategorized

Finerenone, a selective, nonsteroidal mineralocorticoid receptor antagonist, greatly decreased each renal and cardiovascular events, with simply tolerability, within the FIDELIO-DKD trial. Medscape Clinical News
Read Extra

Leave a Reply

Your email address will not be published. Required fields are marked *